Commission launches consultation on responsible nano research

The European Commission has launched a consultation on responsible research in nanosciences and nanotechnologies.

The consultation is part of the Commission's plan to suggest that the EU Member States sign up to a Code of Conduct for this emerging area of science. A broad spectrum of society is addressed by the consultation, from the scientific community and industry to civil society, policy-makers, media and the general public.

"Nanosciences and nanotechnologies have the potential to drive growth and jobs in Europe, and their development and use should not be delayed, unbalanced or left to chance," said EU Science and Research Commissioner Janez Potocnik. "It is important that we pursue this knowledge with full understanding of the possible implications of these new areas of science, and that we do so openly and involving all concerned."

The Commissioner also stressed that the consultation demonstrates the Commission's commitment to 'developing the potential of nanosciences with appropriate safeguards'.

Estimates as to the market potential of nanotechnology products vary, but are all very positive. The Mitsubishi Institute estimated in 2002 that the market would be worth USD 150 billion (around €110 billion) by 2010, while in 2004 the Lux Research group predicted that the market would be worth USD 2.6 trillion (around €1.9 trillion) by 2014.

If this latter estimate is proved to be accurate, it will mean the nanoscience and nanotechnology market overtaking the information and communication technologies (ICT) market, and growing to 10 times the size of the biotechnology market.

However, concerns over safety have put the brakes on some research into the nanosciences and nanotechnologies. The principal concerns cover the ability of nanoparticles to cross natural bio-boundaries, and the prospect of connecting living creatures and human-made materials and systems.

These concerns have led to the development of a new area of research: the responsible management and control of nanosciences. This involves ethics, safety, the environment, individual rights, and the protection of personal data.

The Code of Conduct would encompass basic principles on which to base future developments in nano research, and would invite signatories to take concrete action to ensure that nanotechnologies are developed in a safe manner.

The consultation will close on 21 September.

For further information, please visit:
http://europa.eu/sinapse/directaccess/
science-and-society/public-debates/nano-recommendation/

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...